A Split-Face, Single-Blinded, Randomized Controlled Comparison of 532 nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser versus 532 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Solar Lentigines
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Solar lentigines are the most common form of benign epidermal pigmentation and one of the major cosmetic concerns in Korea. A 532 nm Q-switched neodymium: yttrium-aluminum-garnet (QSND) laser is typically used for the treatment, but the occurrence of post-inflammatory hyperpigmentation (PIH) is not rare. Recently, the use of picosecond (PS) lasers has emerged in pursuit of better outcomes. Objective: To objectively compare the efficacy and safety of 532 nm PS and QSND lasers for the treatment of solar lentigines. Methods: Twenty patients with solar lentigines were enrolled in a prospective, randomized split-face, single- blind study. One side of each face was treated using a 532 nm PS laser, and the other side using a 532 nm QSND laser. After one treatment, all patients were followed up for evaluation after 2, 4, 8, and 12 weeks. The clinical clearance was assessed by three blinded dermatologists using a 5-point quartile improvement scale (QIS). Subjective satisfaction, development of PIH, pain scale during treatment, and adverse problems were also recorded. Results: Clinical clearance measured by QIS showed that the PS laser was more effective than the QSND laser. Subjective satisfaction and pain scale did not significantly differ between the two groups. The incidence of PIH was 5% in sides treated with the PS laser, and 30% with the QSND laser. Conclusion: Both 532 nm PS laser and QSND laser were effective for the treatment of solar lentigines, but the PS laser was more effective with less PIH development.
Abstract
Solar lentigines are the most common form of benign epidermal pigmentation and one of the major cosmetic concerns in Korea. A 532 nm Q-switched neodymium: yttrium-aluminum-garnet (QSND) laser is typically used for the treatment, but the occurrence of post-inflammatory hyperpigmentation (PIH) is not rare. Recently, the use of picosecond (PS) lasers has emerged in pursuit of better outcomes. Objective: To objectively compare the efficacy and safety of 532 nm PS and QSND lasers for the treatment of solar lentigines. Methods: Twenty patients with solar lentigines were enrolled in a prospective, randomized split-face, single- blind study. One side of each face was treated using a 532 nm PS laser, and the other side using a 532 nm QSND laser. After one treatment, all patients were followed up for evaluation after 2, 4, 8, and 12 weeks. The clinical clearance was assessed by three blinded dermatologists using a 5-point quartile improvement scale (QIS). Subjective satisfaction, development of PIH, pain scale during treatment, and adverse problems were also recorded. Results: Clinical clearance measured by QIS showed that the PS laser was more effective than the QSND laser. Subjective satisfaction and pain scale did not significantly differ between the two groups. The incidence of PIH was 5% in sides treated with the PS laser, and 30% with the QSND laser. Conclusion: Both 532 nm PS laser and QSND laser were effective for the treatment of solar lentigines, but the PS laser was more effective with less PIH development.
참고문헌 (15)
- Ortonne JP, "Pigmentary changes of the ageing skin", Br J Dermatol, 122(Suppl 35), pp.21~28 (1990)
- Ortonne JP, "Treatment of solar lentigines", J Am Acad Dermatol, 54(5 Suppl 2), pp.S262~S271 (2006)
- Anderson RR, "Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm", J Invest Dermatol, 93, pp.28~32 (1989)
- Chan HH, "An in vivo trial comparing the use of different types of 532 nm Nd : YAG lasers in the treatment of facial lentigines in Oriental patients", Dermatol Surg, 26, pp.743~749 (2000)
- Noh TK, "Q-Switched 660-nm versus 532-nm Nd: YAG laser for the treatment for facial lentigines in Asian patients: a prospective, randomized, double-blinded, split-face comparison pilot study", Dermatol Surg, 41, pp.1389~1395 (2015)
- Levin MK, "Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: a retrospective photographic review", Lasers Surg Med, 48, pp.181~187 (2016)
- Guss L, "Picosecond 532 nm neodymium-doped yttrium aluminium garnet laser for the treatment of solar lentigines in darker skin types : safety and efficacy", Dermatol Surg, 43, pp.456~459 (2017)
- Negishi K, "Prospective study of removing solar lentigines in Asians using a novel dual-wavelength and dual-pulse width picosecond laser", Lasers Surg Med, 50, pp.851~858 (2018)
- Yoshimura K, "Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals", Plast Reconstr Surg, 105, pp.1097~1108 (2000)
- Todd MM, "A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial", Arch Dermatol, 136, pp.841~846 (2000)
- Negishi K, "Comparative study of treatment efficacy and the incidence of post-inflammatory hyperpigmentation with different degrees of irradiation using two different qualityswitched lasers for removing solar lentigines on Asian skin", J Eur Acad Dermatol Venereol, 27, pp.307~312 (2013)
- Ho SG, "A comparison of Q-switched and long-pulsed alexandrite laser for the treatment of freckles and lentigines in oriental patients", Lasers Surg Med, 43, pp.108~113 (2011)
- Friedmann DP, "Efficacy and safety of intense pulsed light with a KTP filter for the treatment of solar lentigines", Lasers Surg Med, 51, pp.500~508 (2019)
- Forbat E, "Applications of picosecond lasers beyond tattoos : pigment reduction and tissue remodeling", Lasers Med Sci, 32, pp.1219~ (2017)
- Chan JC, "A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians", Lasers Surg Med, 48, pp.23~29 (2016)